NewsDeep Health AI India Limited Board Approves Voluntary Strike-Off of Wholly Owned SubsidiaryDeep Health AI India Limited Board Approves Voluntary Strike-Off of Wholly Owned Subsidiary
Deep Health AI India Limited's Board of Directors approved the voluntary strike-off of its wholly owned subsidiary Microcure Biotech Private Limited during a meeting on April 01, 2026. The subsidiary, which has no business operations and contributed nil turnover with Rs. 2,00,000 net worth in FY 24-25, will be struck off under Section 248(2) of the Companies Act, 2013. The company has fulfilled regulatory compliance by notifying BSE Limited under Regulation 30 of SEBI Listing Regulations, with Managing Director Narayan Singh Rathore confirming no material impact on operations.
*this image is generated using AI for illustrative purposes only.
Deep Health AI India Limited has announced that its Board of Directors approved the voluntary strike-off of wholly owned subsidiary Microcure Biotech Private Limited during a board meeting held on April 01, 2026. The decision was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board Meeting Decision
The board approved filing an application under Section 248(2) of the Companies Act, 2013 for striking off Microcure Biotech Private Limited. The subsidiary is not carrying on any business operations and does not qualify as a material subsidiary of the company.
| Meeting Details: | Information |
|---|---|
| Date: | April 01, 2026 |
| Start Time: | 03:30 P.M. |
| End Time: | 06:05 P.M. |
| Approval: | Voluntary strike-off application |
Subsidiary Financial Contribution
The wholly owned subsidiary's contribution to Deep Health AI India Limited during the last financial year was minimal, reflecting its inactive status.
| Financial Parameter: | FY 24-25 Performance |
|---|---|
| Turnover: | NIL |
| Net Worth: | Rs. 2,00,000 |
| Business Operations: | None |
| Material Subsidiary Status: | Does not qualify |
Regulatory Compliance and Documentation
The company has submitted the board meeting outcome to BSE Limited, fulfilling its disclosure obligations under Regulation 30 of the Listing Regulations. Managing Director Narayan Singh Rathore signed the official communication, which was digitally authenticated on April 01, 2026.
| Regulatory Details: | Information |
|---|---|
| Communication Date: | April 01, 2026 |
| Recipient: | BSE Limited |
| Digital Signature Time: | 18:45:11 +05'30' |
| Annexure: | Detailed subsidiary disclosures |
Impact Assessment
Deep Health AI India Limited has clarified that the voluntary strike-off of Microcure Biotech Private Limited will have no material impact on the company's operations or financial position. The decision appears to be part of corporate housekeeping to streamline the company's subsidiary structure.
Company Background
Deep Health AI India Limited, formerly known as Deep Diamond India Limited, is registered in Udaipur, Rajasthan. The company operates from its registered office at 506-509 Fifth floor, Apeksha, plot no. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan. The company's CIN is L24100MH1994PLC082609.
Historical Stock Returns for Deep Health AI
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.00% | -0.53% | -32.50% | -66.13% | -54.46% | +48.82% |
Will Deep Health AI India Limited acquire or establish new subsidiaries to strengthen its AI healthcare portfolio following this corporate restructuring?
How might this subsidiary consolidation strategy affect Deep Health AI's operational efficiency and cost structure in the upcoming quarters?
Could this streamlining move signal preparation for potential fundraising, IPO plans, or strategic partnerships in the AI healthcare sector?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
